Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bevacizumab for CRVO
NCT00906685Phase 3Completed
- Start
- May 2009
- Primary completion
- Mar 2011
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 3 trial of bevacizumab in central retinal vein occlusion (CRVO). Started May 2009; status: completed.
02
Drugs
bevacizumab
03
Conditions
central retinal vein occlusion (CRVO)
Beyond the preview
Go deeper on NCT00906685.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00906685.